Pioneering new approaches to diagnosis, care, and treatment for patients with red blood cell disorders with novel gene therapies and stem-cell-based treatments that aim to reduce symptoms and prolong life.
The focus of the Chou Laboratory is to investigate the mechanisms of normal hematopoietic development, understand how these become disrupted in hematologic diseases, and create novel tools using induced pluripotent stem cells (iPSCs) to model blood diseases and improve treatment.
Some people slow down in summer, but here at The Children's Hospital of Philadelphia, hot weather is no impediment to making research advances. This week, our roundup of CHOP research in the news covers a broad range of them.
Many parents and clinicians are in a bind between conflicting recommendations about autism. Newly issued recommendations by the U.S. Preventive Services Task Force (USPTSF) suggest that current evidence is not strong enough to justify universal screening for the condition in young children.
Synapses were firing throughout the conference room in the Colket Translational Research Building as attendees at the 2017 Research Institute Scientific Symposium held May 2 learned about their colleagues' intriguing research endeavors. The four sessions' themes aligned smartly with the Research Institute's strategic planning process and overall mission of the Children's Hospital of Philadelphia.
The American Academy of Otolaryngology-Head and Neck Surgery published a guideline in 2011 recommending that “clinicians should not routinely administer or prescribe perioperative antibiotics to children undergoing tonsillectomies.”